ES2017559A6 - Procedimiento para la formulacion de la espiramicina. - Google Patents

Procedimiento para la formulacion de la espiramicina.

Info

Publication number
ES2017559A6
ES2017559A6 ES8903343A ES8903343A ES2017559A6 ES 2017559 A6 ES2017559 A6 ES 2017559A6 ES 8903343 A ES8903343 A ES 8903343A ES 8903343 A ES8903343 A ES 8903343A ES 2017559 A6 ES2017559 A6 ES 2017559A6
Authority
ES
Spain
Prior art keywords
spiramycin
formulation
procedure
granulate
reconstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES8903343A
Other languages
English (en)
Inventor
Alvarez Luis Alfonso Rio
Mateo Ana Calvo
Morales Manuel Esteban
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc Farma SA
Original Assignee
Rhone Poulenc Farma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Farma SA filed Critical Rhone Poulenc Farma SA
Priority to ES8903343A priority Critical patent/ES2017559A6/es
Publication of ES2017559A6 publication Critical patent/ES2017559A6/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)

Abstract

PROCEDIMIENTO PARA LA FORMULACION DE LA ESPIRAMICINA, MAS CONCRETAMENTE UN PROCEDIMIENTO PARA LA FORMULACION DE UN POLVO O GRANULADO MONODOSIS DE ESPIRAMICINA QUE SE RECONSTITUYE CON AGUA EN FORMA DE DISPERSION, CARACTERIZADO PORQUE SE EMPLEA UNO O VARIOS DE LOS SIGUIENTES GRUPOS DE EXCIPIENTES: EDULCORANTES NATURALES Y ARTIFICIALES, AROMATIZANTES POTENCIADORES DEL SABOR Y COLORANTES.
ES8903343A 1989-10-04 1989-10-04 Procedimiento para la formulacion de la espiramicina. Expired - Lifetime ES2017559A6 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES8903343A ES2017559A6 (es) 1989-10-04 1989-10-04 Procedimiento para la formulacion de la espiramicina.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES8903343A ES2017559A6 (es) 1989-10-04 1989-10-04 Procedimiento para la formulacion de la espiramicina.

Publications (1)

Publication Number Publication Date
ES2017559A6 true ES2017559A6 (es) 1991-02-16

Family

ID=8264166

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8903343A Expired - Lifetime ES2017559A6 (es) 1989-10-04 1989-10-04 Procedimiento para la formulacion de la espiramicina.

Country Status (1)

Country Link
ES (1) ES2017559A6 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994007504A1 (fr) * 1992-10-05 1994-04-14 Rhone-Poulenc Rorer S.A. Nouvelles formulations pharmaceutiques de spiramycine

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994007504A1 (fr) * 1992-10-05 1994-04-14 Rhone-Poulenc Rorer S.A. Nouvelles formulations pharmaceutiques de spiramycine

Similar Documents

Publication Publication Date Title
DK251287A (da) Bionedbrydeligt praeparat til anvendelse som implantat med forsinket virkning og fremgangsmaade til fremstilling deraf samt praeparatets anvendelse
NZ227788A (en) Peptide having growth hormone regulatory effects, and compositions
NZ211880A (en) Immunogenic, leukemia-associated viral proteins and vaccines
EP0336760A3 (en) Bone-inducing protein
IL74222A (en) 6-substituted-4-dialkylamino tetrahydrobenz(c,d)indoles,their preparation and pharmaceutical compositions comprising them
BG103219A (en) Benzamidine derivatives and their application as medicamentous forms with ltb-4-antagonist effect
IL121585A0 (en) Immunogenic and immunostimulatory oligosaccharide compositions and methods of preparing and using them
BG102362A (en) New derivatives of amino acids, their preparation and application
BG102891A (en) Enzymic pregranulate for fodder granulate
AU2753188A (en) High strength silicone foam, and methods for making
AU4719089A (en) Preparation of modified star polymers and the use of such polymers as luboil additives
AU1907788A (en) N-aminobutyl-n-phenylarylamide derivatives, their preparation and their application in therapy
IL94103A0 (en) Water-containing formulations with phospholipids,their preparation and application
OA09233A (en) Permanent waving process and compositions.
GR3031581T3 (en) Freeze-dried emulsion containing an active substance.
ES2017559A6 (es) Procedimiento para la formulacion de la espiramicina.
WO1992009694A3 (en) CLONING OF UDP-N-ACETYLGLUCOSAMINE:α-3-D-MANNOSIDE β-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE I
EP0957936A4 (en) RECOMBINANT PAPILLONAVIRUS VACCINE FORMULATIONS
GB2138681B (en) Agricultural compositions, methods of preparing agricultural compositions, and methods of using agricultural compositions
EP0609292A4 (en) Soluble variants of type i membrane proteins, and methods of using them.
AU7528087A (en) Immunogenic fraction active against bilharzioses, its preparation, and immunizing compositions containing it
ES2131482A1 (es) Formulacion acuosa de bambuterol.
IL86796A0 (en) Peptide derivatives,their preparation and their use
AU111089S (en) Electrical connector
EP0371347A3 (en) Cyclic ethers and their use as perfuming or flavouring ingredients